Country: Malta
Language: English
Source: Medicines Authority
PARACETAMOL, DEXTROMETHORPHAN HYDROBROMIDE, PROMETHAZINE HYDROCHLORIDE
GlaxoSmithKline Consumer Health-care UK Trading Limited 980 Great West Road, Brentford, Middlesex, TW8 9GS, United Kingdom
N02BE51
PARACETAMOL 1000 µg/dose DEXTROMETHORPHAN HYDROBROMIDE 15 µg/dose PROMETHAZINE HYDROCHLORIDE 20 µg/dose
ORAL SOLUTION
PARACETAMOL 1000 µg/dose DEXTROMETHORPHAN HYDROBROMIDE 15 µg/dose PROMETHAZINE HYDROCHLORIDE 20 µg/dose
OTC
ANALGESICS
Withdrawn
2006-01-10
Page 1 of 1 Read the complete document
Page 1 of 13 SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Night Nurse 2 QUALITATIVE AND QUANTITATIVE COMPOSITION ACTIVE CONSTITUENTS MG/20 ML Paracetamol Ph Eur 1000.0 Promethazine hydrochloride Ph Eur 20.0 Dextromethorphan hydrobromide Ph Eur 15.0 3 PHARMACEUTICAL FORM Oral solution 4 CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS For the symptomatic relief of colds, chills and influenza at night. 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Route of Administration Oral To be taken at bedtime Maximum daily dose: Only one dose should be taken per night. Do not exceed the stated dose Other products containing paracetamol may be taken during the day but the total daily dose of paracetamol must not exceed 4000mg (including this product) in any 24 hour period. Allow at least four hours between taking any paracetamol-containing product and this product. Should not be used with other cough or cold medicines, or any other antihistamine-containing products, including those used on the skin. Page 2 of 13 Adults and children 12 years and over: One 20 ml measured dose (or four 5 ml spoonfuls). Take just before going to bed. Maximum duration of continued use without medical advice: 3 days. Not to be given to children under 12 years except on medical advice. Elderly: The normal adult dose can be used. 4.3 CONTRAINDICATIONS Hypersensitivity to paracetamol, dextromethorphan, promethazine or any of the other constituents. With, or at risk of developing, respiratory failure (e.g. those with chronic obstructive airways disease or pneumonia, or during an asthma attack or an exacerbation of asthma). Patients taking or have taken monoamine oxidase inhibitors (MAOIs) in the last two weeks. 4.4 SPECIAL WARNINGS AND PRECAUTIONS FOR USE Medical advice must be sought before taking this product in people with: Hepatic or renal impairment. Underlying liver disease increases the risk of paracetamol-related liver damage. Chronic or persistant cough, such as occurs with asthma and emphysema, or where cough is accom Read the complete document